Senior corporate partner in the Linklaters London office focusing on public and private M&A, capital raisings and corporate governance advisory work. He is a member of the firm's Japan desk. James is a relationship partner for major clients including Jardine Matheson, Novartis and Rio Tinto. He led on the £46bn Takeda Pharmaceutical Company recommended offer for Shire plc, the largest ever outbound M&A deal by a Japanese company. James is a member of Linklaters’ practice and innovation steering group, and he leads the practice innovation team within the firm’s corporate group.